semaglutide injectables An Ongoing Crisis: Shortage Raises Dual Concerns for Obesity and Diabetes Treatment Semaglutide IM - Natural Endocrinology

Larger and longer studies in broader populations are needed to fully understand the safety and efficacy in people with alcohol use disorder, but these initial findings are promising. Reference: Hendershot CS, Bremmer MP, Paladino MB, et al

Injections are good at treating more severe deficiencies, says Foxx

Amogen is advancing a biosimilar candidate referencing semaglutide, one of the most widely prescribed GLP-1 receptor agonists for type 2 diabetes and obesity management

Prevention is key

According to NICE guidance (NG28), GLP-1 receptor agonists like Ozempic are typically considered when triple therapy is ineffective, not tolerated or contraindicated, with specific BMI and clinical criteria